Committees

The role of technology, research and innovation in the COVID-19 recovery

Inquiry

In addition to its health impacts, the COVID-19 pandemic has disrupted economic activity, with the OECD estimating that the initial impact on the UK has been a reduction in GDP of more than 25% since the end of March. Research and innovation activity has been affected, with the Campaign for Science and Engineering reporting financial and logistical difficulties for academic institutes, medical research charities and businesses.

This is particularly important given the ability of research and innovation to drive economic growth as the UK seeks to recover from the pandemic, with UKRI having previously estimated that every £1 spent on research and development delivers £7 in economic and social benefit.

The House of Commons Science and Technology Committee will inquire formally into the role of technology, research and innovation in the UK’s economic recovery from COVID-19, as well as the support that the sector itself requires to recover from the pandemic.

Read the call for evidence for more information about this inquiry.

Reports, special reports and government responses

No reports or special reports published.

Correspondence

View all correspondence
Correspondence from the Northern Ireland Office relating to the Committee’s visit to Northern Ireland
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Open PDF
4MB
Correspondence
Correspondence from Rt. Hon Kwasi Kwarteng MP, Secretary of State of Business, Energy and Industrial Strategy, To the Chair regarding the Committee's visit to Glasgow
Inquiries UK space strategy and UK satellite infrastructure, and The role of technology, research and innovation in the COVID-19 recovery
Open PDF
100KB
Correspondence
Correspondence from the Chair to Kwasi Kwarteng MP, Secretary of State for Business, Energy and Industrial Strategy, regarding the Committee's visit to Glasgow
Inquiries UK space strategy and UK satellite infrastructure, and The role of technology, research and innovation in the COVID-19 recovery
Open PDF
122KB
Correspondence

Oral evidence transcripts

View all oral evidence transcripts
6 July 2022
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Professor Nola Hewitt-Dundas (Pro-Vice-Chancellor for Faculty of Arts, Humanities and Social Science at Queens University Belfast), Tim Brundle (Director of Research & Impact at Ulster University), Matthew Malcolm (Creative Industries Development Officer at Arts Council of Northern Ireland), Professor Paul Moore (Director at Future Screens Northern Ireland), Jack Morrow (Chief Technology Officer at RETìníZE), Keith Forster (Director of Strategic Policy at Northern Ireland Department for the Economy), Gordon Lyons MLA (Minister at Northern Ireland Department for the Economy), and Eoin McFadden (Head of Innovation Strategy Unit at Northern Ireland Department for the Economy)
Open PDF
120KB
Open HTML
120KB
Oral Evidence
10 February 2022
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Professor Frank Coton (Senior Vice Principal and Deputy Vice Chancellor (Academic) at University of Glasgow), Karen Watt (Chief Executive at Scottish Funding Council), Dr Gillian Lang (Deputy Director of Science at Glasgow Science Centre), Dr Lynne O'Hare (Chief Commercial Officer at National Manufacturing Institute Scotland), Elaine Gemmell (Head of Regulatory Affairs at Scottish Health Innovations Ltd), Simon Andrews (Executive Director at Fraunhofer UK), and Dr Stuart Hannah (Founder at MicroPlate Dx)
Open PDF
123KB
Open HTML
123KB
Oral Evidence
25 November 2021
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Andy Street CBE (Mayor at West Midlands Combined Authority), Dr Clive Hickman (Chief Executive at The Manufacturing Technology Centre), Professor Simon Collinson (Director at City-REDI, University of Birmingham), Tony Kinsella (Chief Executive at Lucideon), Stephen Malone (Group CEO at Malone Group), Professor Martin Freer (Director at Energy Research Accelerator (ERA)), and Professor Daniel Smith (Executive Director, Global Cell and Gene Therapy Portfolio at Cobra Biologics)
Open PDF
123KB
Open HTML
123KB
Oral Evidence

Written evidence

View all written evidence
West Midlands Combined Authority (CRV0069)
Open PDF
165KB
Open HTML
165KB
The Manufacturing Technology Centre (MTC) (CRV0068)
Open PDF
27KB
Open HTML
27KB
LumiraDx (CRV0066)
Open PDF
33KB
Open HTML
33KB

Other publications

No other publications published.

Contact us

We can’t usually help you with an individual problem or a specific complaint.

  • Email: commonssitc@parliament.uk
  • Phone: 020 7219 5023 (general enquiries) |020 7219 0731 (media enquiries)
  • Address: Science, Innovation and Technology Committee, House of Commons, London, SW1A 0AA